Strategies targeting the IL-4/IL-13 axes in disease.

Related Articles

Strategies targeting the IL-4/IL-13 axes in disease.

Cytokine. 2015 Aug 5;

Authors: May RD, Fung M

Abstract
IL-4 and IL-13 are pleiotropic Th2 cytokines produced by a wide variety of different cell types and responsible for a broad range of biology and functions. Physiologically, Th2 cytokines are known to mediate host defense against parasites but they can also trigger disease if their activities are dysregulated. In this review we discuss the rationale for targeting the IL-4/IL-13 axes in asthma, atopic dermatitis, allergic rhinitis, COPD, cancer, inflammatory bowel disease, autoimmune disease and fibrotic disease as well as evaluating the associated clinical data derived from blocking IL-4, IL-13 or IL-4 and IL-13 together.

PMID: 26255210 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Breaking: Sunovion axes sales reps for asthma meds in consolidation move – FiercePharma

Breaking: Sunovion axes sales reps for asthma meds in consolidation move
FiercePharma
The company is consolidating its national respiratory sales organization, laying off a number of reps to streamline how it promotes its allergy and asthma drugs, according to an emailed statement provided to FiercePharma by the drugmaker's vice
Sunovion to lay off drug reps, reportedly by the hundredsBoston Business Journal

all 2 news articles »

View full post on asthma – Google News